FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2026
Back to search
Official data from USPTO
ESQLABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ESQLABS
ST13
US500000079421787Class
9, 41, 42
Filing
79421787
Registration
8248555
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/12/2026
Trademark type
Word
Nice classes
9, 41, 42
Filing date
11/27/2024
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
esqlabs GmbH
Representatives
Kristen H. Mowery Hodgson Russ LLP
Technical classification
Nice Classes
Class 9Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Blank digital storage media; Electronic publicationsnamely training manuals in electronic form; downloadable computer software and software platforms for modelling and simulationin particular in the field of pharmacychemistry or plant protection; downloadable modelling and simulation computer software and platforms for physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP); downloadable computer software and software platforms for investigating organ damage; downloadable computer software and software platforms for investigating drug-drug interactions (DDI); downloadable computer software and software platforms for translational modelling for human initial dose prediction; downloadable computer software and software platforms for developingcalculating and analysing mathematical models and simulationsin particular in the field of life sciences; downloadable graphical user interface software being software and software platforms with graphical user interfaces for various operating systems and platforms; downloadable computer software and software platforms for solving numerical problems; downloadable computer software and software platforms for analysing datain particular statistically; downloadable computer software and software platforms for graphical visualisation of simulation results and observed data; downloadable computer software packages for programming languages in the nature of downloadable software development kits (SDK); electronic databases in the field of pharmacychemistry or plant protection recorded on computer media
Class 41
Educationtraining and teachingteachingtrainingtutoring and courses of instruction at the undergraduategraduate and post-graduate level; training and education services being instruction in the field of pharmacychemistry or plant protection; organisation and provision of training courses in the field of pharmacychemistry and plant protection; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for modelling and simulationin particular in the fields of pharmacychemistry and plant protection; organisation and provision of training coursesconferencesworkshops and seminars relating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; organisation and provision of training coursesconferencesworkshops and seminars relating to the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for investigating organ damage; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for investigating drug-drug interactions (DDI); organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for translational modelling for initial dose prediction in humans; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for the developmentcalculation and analysis of mathematical models and simulationsin particular in the field of life sciences; organisation and provision of training coursesconferencesworkshops and seminars relating to graphical user interface software and software platforms for various operating systems and platforms; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for solving numerical problems; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for the statistical evaluation of data; organisation and provision of training coursesconferencesworkshops and seminars relating to software and software platforms for the graphical representation of simulation results and observed data; organisation and provision of training coursesconferencesworkshops and seminars relating to the development and implementation of packages for programming languages being software development kits (SDK); organisation and provision of training coursesconferencesworkshops and seminars relating to the creation and integration of electronic databases; creation of training materials in the field of pharmacychemistryplant protection both in hard copy and electronic forms including booksvideossoftware; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for modelling and simulationin particular in the fields of pharmacychemistry and plant protection; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for studying organ damage; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for the study of drug-drug interactions (DDI); creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for translational modelling for human initial dose prediction; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for developingcalculating and analysing mathematical models and simulationsin particular in the field of life sciences; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to graphical user interface software and software platforms for different operating systems and platforms; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for solving numerical problems; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for statistical analysis of data; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to software and software platforms for the graphical visualisation of simulation results and observed data; creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to the development and implementation of packages for programming languagesbeing software development kits (SDK); creation of training materialsboth in hard copy and electronic forms including booksvideossoftwarerelating to the creation and integration of electronic databases
Class 42
IT consulting services relating to installationmaintenance and repair of computer software; software as a service (SaaS) featuring software for modelling and simulation in the field of pharmacychemistry and plant protection; platform as a service (PaaS) featuring computer software platforms for modelling and simulation in the field of pharmacychemistry or plant protection; computer services for data analysescomputerized analysis and interpretation of data concerning pharmacychemistryplant protection; conducting of technical data analyses in the field of pharmacychemistry or plant protection; designdevelopmentprogramming and implementation of software and software platforms for modelling and simulationin particular in the field of pharmacychemistry or plant protection; designdevelopmentprogramming and implementation of physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; designdevelopmentprogramming and implementation of software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; designdevelopmentprogramming and implementation of software and software platforms for investigating organ damage; designdevelopmentprogramming and implementation of software and software platforms for investigating drug-drug interactions (DDI); designdevelopmentprogramming and implementation of software and software platforms for translational modelling for human initial dose prediction; designdevelopmentprogramming and implementation of software and software platforms for the developmentcalculation and analysis of mathematical models and simulationsin particular in the field of life sciences; designdevelopmentprogramming and implementation of software and software platforms with graphical user interfaces for various operating systems and platforms; designdevelopmentprogramming and implementation of software and software platforms for solving numerical problems; designdevelopmentprogramming and implementation of software and software platforms for statistical analysis of data; designdevelopmentprogramming and implementation of software and software platforms for the graphical visualisation of simulation results and observed data; designdevelopmentprogramming and implementation of packages for programming languages being software development kits (SDK); designdevelopmentprogramming and implementation of electronic databases recorded on computer media; provision of temporary use of online non-downloadable software and software platforms for modelling and simulationin particular in the field of pharmacychemistry or plant protection; provision of temporary use of online non-downloadable physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platformsin particular in the field of pharmacychemistry or plant protection; provision of temporary use of online non-downloadable software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; provision of temporary use of online non-downloadable software and software platforms for the investigation of organ damage; provision of temporary use of online non-downloadable software and software platforms for investigating drug-drug interactions (DDI); provision of temporary use of online non-downloadable software and software platforms for translational modelling for human initial dose prediction; provision of temporary use of online non-downloadable software and software platforms for the developmentcalculation and analysis of mathematical models and simulationsin particular in the field of life sciences; provision of temporary use of online non-downloadable graphical user interface software being software and software platforms for various operating systems and platforms; provision of temporary use of online non-downloadable software and software platforms for solving numerical problems; provision of temporary use of online non-downloadable software and software platforms for analysing datain particular statistically; provision of temporary use of online non-downloadable software and software platforms for graphical visualisation of simulation results and observed data; technological and scientific consulting services in the field of pharmacychemistry or plant protection; IT consultancyadvisory and information services related to installationmaintenance and repair of computer software; IT consultancyadvisory and information services relating to software and software platforms for modelling and simulationin particular in the field of pharmacychemistry or plant protection; IT consultancyadvisory and information services relating to physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platformsin particular in the field of pharmacychemistry or plant protection; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for studying organ damage; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for investigating drug-drug interactions (DDI); IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for translational modelling for human initial dose prediction; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for the developmentcalculation and analysis of mathematical models and simulationsin particular in the field of life sciences; IT consultancyadvisory and information services relating to installationmaintenance and repair of graphical user interface computer software and software platforms for various operating systems and platforms; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for solving numerical problems; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for analysing datain particular statistically; IT consultancyadvisory and information services relating to installationmaintenance and repair of computer software and software platforms for the graphical visualisation of simulation results and observed data; IT consultancyadvisory and information services relating to the development and implementation of packages for programming languages being software development kits (SDK); IT consultancyadvisory and information services relating to the creation and integration of electronic databases; installationsetting up and maintenance of software; installationsetting up and maintenance of software and software platforms for modelling and simulationin particular in the field of pharmacychemistry or plant protection; installationsetting up and maintenance of physiologically-based pharmacokinetics (PBPK) and quantitative systems pharmacology (QSP) modelling and simulation software and platforms; installationsetting up and maintenance of software and software platforms for the development of preclinical or clinical physiologically-based pharmacokinetics (PBPK) software models; installationsetting up and maintenance of software and software platforms for investigating organ damage; installingsetting up and maintenance of software and software platforms for investigating drug-drug interactions (DDI); installationsetting up and maintenance of software and software platforms for translational modelling for human initial dose prediction; installingsetting up and maintenance of software and software platforms for developingcalculating and analysing mathematical models and simulationsin particular in the field of life sciences; installingsetting up and maintenance of software and software platforms with graphical user interfaces for various operating systems and platforms; installingsetting up and maintenance of software and software platforms for solving numerical problems; installingsetting up and maintenance of software and software platforms for analysing datain particular statistically; installingsetting up and maintenance of software and software platforms for the graphical visualisation of simulation results and observed data; installationsetting up and maintenance of packages for programming languages being software development kits (SDK); installationsetting up and maintenance of electronic databases; medical and pharmaceutical research services
Publications
History of USPTO decisions and trademark events.
23 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2026
PUBO
PUBLISHED FOR OPPOSITION
03/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/26/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/26/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/26/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/26/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/26/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2026
RFNT
REFUSAL PROCESSED BY IB
08/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/24/2025
RFRR
REFUSAL PROCESSED BY MPU
07/24/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/30/2025
CNRT
NON-FINAL ACTION WRITTEN
05/29/2025
DOCK
ASSIGNED TO EXAMINER
05/19/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/25/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/17/2025
Continuous trademark protection
Get notified about every new filing that threatens ESQLABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.